Centessa Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
State or Government | 5,798 | 0.00513% |
Private Companies | 28,510 | 0.0252% |
Individual Insiders | 2,389,702 | 2.11% |
General Public | 23,324,917 | 20.6% |
VC/PE Firms | 39,606,764 | 35% |
Institutions | 47,688,553 | 42.2% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
19,963,157 | US$172.3m | 0% | 42.51% | |||
9,961,789 | US$86.0m | 0% | 5.26% | |||
9,681,818 | US$83.6m | 0% | 1.32% | |||
5,618,779 | US$48.5m | 0% | 1.38% | |||
3,931,818 | US$33.9m | 0% | 24.28% | |||
3,083,307 | US$26.6m | 0% | 0.5% | |||
3,002,045 | US$25.9m | 0% | 2.0% | |||
2,958,079 | US$25.5m | 16.5% | no data | |||
2,937,615 | US$25.4m | 0% | 64.32% | |||
2,787,194 | US$24.1m | 0% | no data | |||
2,330,327 | US$20.1m | 26.3% | 0.04% | |||
2,250,000 | US$19.4m | -22.3% | 0.03% | |||
2,136,931 | US$18.4m | 76.1% | no data | |||
2,060,100 | US$17.8m | 0% | 2.58% | |||
2,040,816 | US$17.6m | 0% | 1.45% | |||
1,412,500 | US$12.2m | 39.5% | 0.28% | |||
1,245,000 | US$10.7m | 0% | 1.87% | |||
1,156,723 | US$10.0m | 3.67% | no data | |||
1,104,014 | US$9.5m | 282% | 0.06% | |||
923,120 | US$8.0m | 5.41% | no data | |||
870,190 | US$7.5m | 0.61% | no data | |||
830,546 | US$7.2m | 4.38% | 1.31% | |||
696,096 | US$6.0m | 0% | 0.91% | |||
561,600 | US$4.8m | 0% | 0.25% | |||
485,174 | US$4.2m | 27.3% | 0.11% |